Lifecore CEO James Hall resigns; Paul Josephs appointed CEO and director effective May 20

LIFECORE BIOMEDICAL, INC. DE

James G. Hall resigned as director, President and CEO effective May 19, 2024.
Paul Josephs appointed President, CEO and director effective May 20, 2024.
Josephs previously CEO of Woodstock Sterile Solutions (CDMO) from April 2021 to May 2024.
Granted 525,000 RSUs (25k vested immediately, 100k/year over 5 years) and up to 1.5M PSUs with performance price targets from $7.50 to $35.00 per share.
Josephs enters Tier 1 Change in Control Severance Plan benefits.

item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James G. Hall

President and Chief Executive Officer

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-05-19
Successor: Paul Josephs
Filed: May 22, 2024, 7:59 PM ET

Effective May 19, 2024, James G. Hall resigned as a director of the Company and ceased serving as the Company’s President and Chief Executive Officer.

Appointed

Paul Josephs

President and Chief Executive Officer

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-05-20
Filed: May 22, 2024, 7:59 PM ET

On May 20, 2024, Paul Josephs began serving as the Company’s President and Chief Executive Officer and was elected as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James G. Hall resigned as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Effective May 19, 2024, James G. Hall resigned as a director of the Company and ceased serving as the Company’s President and Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Josephs was appointed as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On May 20, 2024, Paul Josephs began serving as the Company’s President and Chief Executive Officer and was elected as a director of the Company.

View on SEC.gov

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-24-000071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.